At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating LY3074828, Auto-injector (AI), and 1 other intervention for Healthy. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The purpose of this study is to look at the amount of the study drug, LY3074828, that gets into the blood stream and how long it takes the body to get rid of LY3074828 when given as different formulations. The tolerability of LY3074828 will also be evaluated and information about any side effects experienced will be collected. Screening is required within 28 days prior to the start of the study. For each participant, the study will last about 12 weeks, not including screening.
Study Details
Timeline
Interventions
Administered SC
Administered SC
AI to administer LY3074828
PFS to administer LY3074828